Benzinga Money is a reader-supported publication. We may earn a commission from the advertisers associated with this article. Read our Advertiser Discloser.
Every year, wisdom teeth removal surgeries traumatize millions. Despite significant technological improvements, they’re painful, uncomfortable procedures. Still, patients have no choice but to spend more than $3 billion annually on them. However, one revolutionary company is gearing up to create an earthquake in that market. Not because it wants to disrupt it, but because it wants to eliminate it.
A dentist with 25 years of experience and three successful startups under his belt has assembled a team of experts. Together, they have developed a minimally invasive method that stops wisdom teeth formation. The procedure has been 100% effective in animal trials. TriAgenics offers you the opportunity to invest in its current raise on StartEngine.
TriAgenics Can Do It
The history of dentistry is full of examples where technological leaps made previously well-established interventions obsolete. Before dental implants, the most common solution for missing teeth was removable dentures or fixed bridges. Now, dental implants are a $4.43 billion industry. Dental lasers and clear aligners have similarly disrupted the field, with annual spending reaching $6.61 billion. TriAgenics’ product is poised to make an even bigger impact, as it aims to eliminate the need for wisdom teeth removal surgery and secure a big slice of its total addressable market estimated to be around $2.5 billion.
ZERO3 TBA
The ‘ZERO3 TBA’ procedure developed by TriAgenics is simple to understand. It warms the tooth bud necessary for tooth development. Within minutes, the tooth bud becomes permanently unable to form a tooth. Here’s why this method makes much more sense than removing wisdom teeth the old-fashioned way: there’s no surgery, no general anesthesia, no incisions, no painful recovery, and no need for opioid prescriptions. Children ages six to twelve can visit their dentist’s office and get the ZERO3 TBA procedure done on all four wisdom teeth in just 30 minutes. For comparison, it currently takes about 45 minutes to remove just one wisdom tooth.
Animal trials have already been completed, during which ZERO3 TBA demonstrated 100% efficacy. The FDA’s 510(k) form is next in line, which could significantly speed up the process. While not required, the company plans to follow FDA approval with human trials. TriAgenics is very optimistic and aims to start selling its product in 2025. The company has gone out of its way to protect its intellectual property, securing 32 U.S. and international patents that provide legal protection as it enters the Canadian, Mexican, European, and Australian markets.
Given the startup’s prospects, it’s no surprise that it has already raised over $4 million in this round. Learn more about TriAgenics, Zero3 TBA treatment and the company’s current crowdfunding raise on StartEngine.
Consider investing in TriAgenics today.
More From Benzinga
Disclaimer: Please be advised that alternative investments carry a risk of monetary loss. Neither Benzinga nor its staff recommends that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. All information contained on this website is provided as general commentary for informative and entertainment purposes and does not constitute investment advice. Benzinga will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on this information, whether specifically stated in the above Terms of Service or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
